24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CanBreed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
10:29
Intel VP: “We had 11 or 12 layers of management... now it’s 5 or 6”
21:48
From textile recycling to autonomous vessels: The vision behind the Dream Team startups
20:25
ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”
More stories
Buzz
Most popular
Daily
Weekly
1
Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing
2
Check Point raises $1.75 billion, potentially eyeing AI expansion
3
Hapag-Lloyd eyes ZIM acquisition, workers push back
4
Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
CanBreed
4 stories about CanBreed
CTech Meets: An inside look at Israel’s new Cannabis farm
02.05.21
|
James Spiro
CanBreed has opened the country’s largest cannabis trialing farm - and CTech was invited to take a look
Cannabis genetics and seeds company CanBreed completes development of stable hybrid seeds
29.12.20
|
James Spiro
The news follows a recent purchase of a 3.5-acre hemp farm to help distribute 12.5 million seeds across the US
CRISPR-patented cannabis company CanBreed purchases California hemp farm
01.12.20
|
James Spiro
The company, which develops technology for the production of stable and enhanced cannabis seeds will start U.S. marketing next year
CanBreed secures patent for editing medical cannabis seeds
02.09.20
|
James Spiro
The company wants to expedite its stable seeds enhancement for commercial purposes by using gene-editing technology, but still faces regulatory hurdles due to EU GMO ban on CRISPR technology